Revelation Biosciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell REVB and other ETFs, options, and stocks.About REVB
Revelation Biosciences, Inc. engages in the development of immunologic-based therapies for the prevention and treatment of disease. Its product candidates include REVTx-99b, its lead therapeutic candidate being developed for allergic rhinitis and chronic nasal congestion, REVDx 501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation, and REVTx 200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity.
REVB Key Statistics
Stock Snapshot
With a market cap of 2.98M, Revelation Biosciences(REVB) trades at $4.18. The stock has a price-to-earnings ratio of -0.09.
On 2026-11-11, Revelation Biosciences(REVB) stock moved within a range of $3.92 to $4.36. With shares now at $4.18, the stock is trading +6.6% above its intraday low and -4.1% below the session's peak.
Trading volume for Revelation Biosciences(REVB) stock has reached 11.48K, versus its average volume of 14.69K.
The stock's 52-week range extends from a low of $3.08 to a high of $40.60.
The stock's 52-week range extends from a low of $3.08 to a high of $40.60.
REVB News
Revelation Biosciences Inc. (REVB) has disclosed a new risk, in the Debt & Financing category. Revelation Biosciences Inc. faces a significant going‑concern ri...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.